BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15833861)

  • 1. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
    Komura E; Tonetti C; Penard-Lacronique V; Chagraoui H; Lacout C; Lecouédic JP; Rameau P; Debili N; Vainchenker W; Giraudier S
    Cancer Res; 2005 Apr; 65(8):3281-9. PubMed ID: 15833861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis.
    Bock O; Neusch M; Büsche G; Mengel M; Kreipe H
    Eur J Haematol; 2004 Apr; 72(4):239-44. PubMed ID: 15089760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis.
    Rameshwar P; Narayanan R; Qian J; Denny TN; Colon C; Gascon P
    J Immunol; 2000 Aug; 165(4):2271-7. PubMed ID: 10925316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes.
    Cavin LG; Romieu-Mourez R; Panta GR; Sun J; Factor VM; Thorgeirsson SS; Sonenshein GE; Arsura M
    Hepatology; 2003 Dec; 38(6):1540-51. PubMed ID: 14647065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
    Ray A; Dhar S; Ray BK
    Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.
    Giraudier S; Chagraoui H; Komura E; Barnache S; Blanchet B; LeCouedic JP; Smith DF; Larbret F; Taksin AL; Moreau-Gachelin F; Casadevall N; Tulliez M; Hulin A; Debili N; Vainchenker W
    Blood; 2002 Oct; 100(8):2932-40. PubMed ID: 12351405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
    Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
    J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
    Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
    Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
    Chang NS
    Biochem Biophys Res Commun; 2000 Jan; 267(1):194-200. PubMed ID: 10623598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
    Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
    Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression.
    Komura E; Chagraoui H; Mansat de Mas V; Blanchet B; de Sepulveda P; Larbret F; Larghero J; Tulliez M; Debili N; Vainchenker W; Giraudier S
    Exp Hematol; 2003 Jul; 31(7):622-30. PubMed ID: 12842707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells.
    Lin CC; Chiang LL; Lin CH; Shih CH; Liao YT; Hsu MJ; Chen BC
    Eur J Pharmacol; 2007 Apr; 560(2-3):101-9. PubMed ID: 17307160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
    Arsura M; FitzGerald MJ; Fausto N; Sonenshein GE
    Cell Growth Differ; 1997 Oct; 8(10):1049-59. PubMed ID: 9342183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway.
    Lee KY; Ho SC; Lin HC; Lin SM; Liu CY; Huang CD; Wang CH; Chung KF; Kuo HP
    Am J Respir Cell Mol Biol; 2006 Oct; 35(4):407-14. PubMed ID: 16690986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.